Supramolecular nanoprodrug based on a chloride channel blocker and glycosylated pillar[5]arenes for targeted chemoresistance cancer therapy.
Journal
Chemical communications (Cambridge, England)
ISSN: 1364-548X
Titre abrégé: Chem Commun (Camb)
Pays: England
ID NLM: 9610838
Informations de publication
Date de publication:
23 Mar 2023
23 Mar 2023
Historique:
pubmed:
14
3
2023
medline:
25
3
2023
entrez:
13
3
2023
Statut:
epublish
Résumé
A supramolecular nanoprodrug (DOX@GP5⊃Pro-NFA) was constructed based on the host-guest complexation of chloride channel blocker prodrug (Pro-NFA) and glycosylated pillar[5]arene (GP5), which could target tumor cells
Substances chimiques
Chlorides
0
Prodrugs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM